Answers are grounded in this paper and cite their sources.
Developing individualized care from precision medicine through treatment pathways is not an oxymoronic concept. We can achieve congruent solutions if the objectives of precision medicine and treatment pathways are aligned. Therefore, the successful amalgamation of these two methods to direct optimal treatment choices for patients will require a quid pro quo relationship.
No takes yet. Share an insight, caveat, or question.
Ray D. Page (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: